Michelle N. Messmer

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

Annelise G. Snyder, Nicholas Hubbard, Michelle N. Messmer et al. · Science Immunology · 2019 · 380 citations · Full text

Life Sciences, Immunology, Oncology +17

Interleukin-17 Is Required for T Helper 1 Cell Immunity and Host Resistance to the Intracellular Pathogen Francisella tularensis

Yinyao Lin, Shane Ritchea, Alison Logar et al. · Immunity · 2009 · 288 citations · Full text

Life Sciences, Immunology, Microbiology +17

β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy

Mark J. Bucsek, Guanxi Qiao, Cameron R. MacDonald et al. · Cancer Research · 2017 · 276 citations

Medicine, Immunology, Oncology +17

RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity

Susana Orozco, Brian P. Daniels, Nader Yatim et al. · Cell Reports · 2019 · 120 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes

Amy Ku, Jason B. Muhitch, Colin Powers et al. · eLife · 2016 · 111 citations · Full text

Life Sciences, Immunology, Oncology +17